Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Skye Bioscience, Inc. | Director, 10%+ Owner | Common Stock | 8.39M | $83.9M | $10.00 | Mar 13, 2024 | By 5AM Ventures VII, L.P. |
Skye Bioscience, Inc. | Director, 10%+ Owner | Common Stock | 1.72M | $17.2M | $10.00 | Mar 13, 2024 | By 5AM Ventures II, L.P. |
Skye Bioscience, Inc. | Director, 10%+ Owner | Common Stock | 67.8K | $678K | $10.00 | Mar 13, 2024 | By 5AM Co-Investors II, L.P. |
Pear Therapeutics, Inc. | Director, 10%+ Owner | Class A Common Stock | 14.6M | Dec 3, 2021 | by 5AM Ventures IV, L.P. | ||
Pear Therapeutics, Inc. | Director, 10%+ Owner | Class A Common Stock | 3.37M | Dec 3, 2021 | by 5AM Opportunities I, L.P. | ||
Pear Therapeutics, Inc. | Director, 10%+ Owner | Class A Common Stock | 610K | Dec 3, 2021 | by 5AM Co-Investors IV, L.P. | ||
Skye Bioscience, Inc. | Director, 10%+ Owner | Stock Option (Right to Buy) | 35K | Feb 29, 2024 | Direct | ||
Enliven Therapeutics, Inc. | Director, 10%+ Owner | Stock Option (right to buy) | 27.6K | Feb 23, 2023 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
SKYE | Skye Bioscience, Inc. | Mar 13, 2024 | 1 | $4.5M | 4 | Mar 15, 2024 | Director, 10%+ Owner |
SKYE | Skye Bioscience, Inc. | Feb 29, 2024 | 1 | $0 | 4 | Mar 4, 2024 | Director |
SKYE | Skye Bioscience, Inc. | Jan 31, 2024 | 1 | $12M | 4 | Feb 2, 2024 | Director, 10%+ Owner |
SKYE | Skye Bioscience, Inc. | Nov 6, 2023 | 1 | $0 | 4 | Nov 6, 2023 | Director |
SKYE | Skye Bioscience, Inc. | Aug 25, 2023 | 1 | $0 | 4 | Aug 29, 2023 | Director |
SKYE | Skye Bioscience, Inc. | Aug 18, 2023 | 6 | $8.78M | 4 | Aug 22, 2023 | Director, 10%+ Owner |
SKYE | Skye Bioscience, Inc. | Aug 18, 2023 | 0 | $0 | 3 | Aug 22, 2023 | Director, 10%+ Owner |
ELVN | Enliven Therapeutics, Inc. | Feb 23, 2023 | 1 | $0 | 4 | Apr 6, 2023 | Director, 10%+ Owner |
ELVN | Enliven Therapeutics, Inc. | Feb 23, 2023 | 2 | $0 | 4 | Feb 27, 2023 | Director |
ELVN | Enliven Therapeutics, Inc. | Feb 23, 2023 | 0 | $0 | 3 | Feb 27, 2023 | Director |
PEARQ | Pear Therapeutics, Inc. | Dec 3, 2021 | 4 | $2M | 4 | Dec 7, 2021 | Director, 10%+ Owner |
PEARQ | Pear Therapeutics, Inc. | Dec 3, 2021 | 0 | $0 | 3 | Dec 7, 2021 | Director, 10%+ Owner |